Resolaris: Ph Ib/II ATYR1940-C-004 data

Top-line data from the open-label, placebo-controlled, intra-patient dose-escalation, international Phase Ib/II ATYR1940-C-004 trial in 18 patients with LGMD2B (n=10) or FSHD (n=8) showed that IV Reso...